{{medical}}
{{Drugbox
| IUPAC_name = 2-巯基乙磺酸钠<br />sodium 2-sulfanylethanesulfonate
| image = Mesna.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|mesna}}
| pregnancy_AU  = B1
| pregnancy_US  = B
| legal_AU = S4
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = 口服，静脉注射

<!--Pharmacokinetic data-->
| bioavailability = 45–79%（口服）
| metabolism = 在循环系统中[[氧化|氧化]]
| elimination_half-life = 0.36–8.3小时
| excretion = [[肾脏|肾脏]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 19767-45-4
| ATC_prefix = R05
| ATC_suffix = CB05
| ATC_supplemental = {{ATC|V03|AF01}}
| PubChem = 29769
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 27663
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = NR7O1405Q9
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01459
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 975

<!--Chemical data-->
| C=2 | H=5 | Na=1 | O=3 | S=2 
| molecular_weight = 164.181 [[克|g]]/[[摩尔|mol]]
| smiles = [Na+].[O-]S(=O)(=O)CCS
| InChI = 1/C2H6O3S2.Na/c3-7(4,5)2-1-6;/h6H,1-2H2,(H,3,4,5);/q;+1/p-1
| InChIKey = XOGTZOOQQBDUSI-REWHXWOFAG
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C2H6O3S2.Na/c3-7(4,5)2-1-6;/h6H,1-2H2,(H,3,4,5);/q;+1/p-1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XOGTZOOQQBDUSI-UHFFFAOYSA-M
}}

'''美司钠'''（[[国际非专利药品名称|INN]]：'''Mesna'''，{{IPAc-en|icon|ˈ|m|ɛ|z|n|ə}}），又名'''巯乙磺酸钠'''，是一种主要用于辅助[[环磷酰胺|环磷酰胺]]和[[异环磷酰胺|异环磷酰胺]][[化疗|化疗]]的[[有机硫化合物|有机硫化合物]]。它由{{link-en|百特国际|Baxter International}}以'''Uromitexan'''和'''Mesnex'''作为商品名销售。它的英文名“Mesna”由是表示[[巯基|巯基]]的''m''，表示[[乙基|乙基]]的''e''，表示[[磺酸|磺酸]]基的''s''，和表示[[钠|钠]]的''na''组成的。

== 用途 ==
=== 作为化疗佐剂 ===
美司钠在临床上用于降低环磷酰胺和异环磷酰胺化疗引起病人出现[[血尿|血尿]]及[[出血性膀胱炎|出血性膀胱炎]]的可能性。环磷酰胺和异环磷酰胺在[[膀胱|膀胱]]中会被转化成[[丙烯醛|丙烯醛]]，而后者具有对膀胱[[上皮细胞|上皮细胞]]的高度性，能够引起出血性膀胱炎，甚至[[膀胱癌|膀胱癌]]。<ref>{{Cite journal 
| last1 = Cox | first1 = P. J. 
| title = Cyclophosphamide cystitis—Identification of acrolein as the causative agent 
| doi = 10.1016/0006-2952(79)90222-3 
| journal = Biochemical Pharmacology 
| volume = 28 
| issue = 13 
| pages = 2045–2049 
| year = 1979 
| pmid =  475846
| pmc = 
}}</ref><ref>{{Cite journal 
| last1 = Cox | first1 = P. J. 
| title = Cyclophosphamide cystitis and bladder cancer. A hypothesis 
| doi = 10.1016/0014-2964(79)90296-2 
| journal = European Journal of Cancer (1965) 
| volume = 15 
| issue = 8 
| pages = 1071–2013 
| year = 1979 
| pmid =  
| pmc = 
}}</ref> 美司钠的巯基部分能够与丙烯醛的碳碳双键反应，生成无毒无反应活性的[[硫醚|硫醚]]复合物并排泄出人体，从而在不影响疗效的情况下起到了[[泌尿系统|泌尿系统]]保护剂的作用。<ref>{{Cite journal 
| last1 = Brock | first1 = N. 
| last2 = Pohl | first2 = J. 
| last3 = Stekar | first3 = J. 
| doi = 10.1007/BF00410691 
| title = Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds 
| journal = Journal of Cancer Research and Clinical Oncology 
| volume = 100 
| issue = 3 
| pages = 311–320 
| year = 1981 
| pmid =  6792207
| pmc = 
}}</ref><ref name="gale">{{Cite book|last=Thackery |first=Ellen |title=The Gale Encyclopedia of Cancer: L-Z |publisher=Thomson Gale |location=Detroit |year=2002 |page=689-690 |isbn=0-7876-5611-9}}</ref> 同时它还有[[抗氧化剂|抗氧化剂]]的作用，而这进一步保护了泌尿系统，使其免受化疗药物代谢产物的伤害。<ref name="pmid11239029">{{cite journal |author=Mashiach E, Sela S, Weinstein T, Cohen HI, Shasha SM, Kristal B |title=Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure |journal=Nephrol. Dial. Transplant. |volume=16 |issue=3 |pages=542–51 |pmid=11239029 |doi= 10.1093/ndt/16.3.542|url=http://ndt.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11239029|date=March 2001}}</ref>

=== 其它 ===
美司钠还被用作[[祛痰药|祛痰药]]，用于[[慢性支气管炎|慢性支气管炎]]、[[阻塞性肺炎|阻塞性肺炎]]等疾病引起的咳[[痰|痰]]困难。它的作用机理和[[乙酰半胱氨酸|乙酰半胱氨酸]]相同。<ref>{{Cite journal 
| last1 = Yuta | first1 = A. 
| last2 = Baraniuk | first2 = J. N. 
| doi = 10.1007/s11882-005-0044-6 
| title = Therapeutic approaches to mucus hypersecretion 
| journal = Current Allergy and Asthma Reports 
| volume = 5 
| issue = 3 
| pages = 243–251 
| year = 2005 
| pmid =  15842963
| pmc = 
}}</ref> 此用途的美司钠商品名为'''Mistabron'''和'''Mistabronco'''。<ref>{{cite web |url=http://home.intekom.com/pharm/ucb/mistabrn.html |title=Mistabron Ampoules |date=August 1973 |publisher=South African Electronic Package Inserts |accessdate=2008-08-12}}</ref>

== 给药途径 ==
在用于化疗时，美司钠一般为静脉注射，但有时也会口服给药。<ref name="gale" /><ref name="pmid14676103">{{cite journal |author=Mace JR, Keohan ML, Bernardy H, ''et al.'' |title=Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide |journal=Clin. Cancer Res. |volume=9 |issue=16 Pt 1 |pages=5829–34 |pmid=14676103 |doi= |url=http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=14676103|date=December 2003}}</ref> 用于祛痰的美司钠则是通过雾化吸入（如喷剂）或气管滴入的。

== 副作用 ==
在常规剂量下[[副作用|副作用]]通常很少见。可能发生的有：[[过敏反应|过敏反应]]、[[恶心|恶心]]、[[呕吐|呕吐]]、[[腹泻|腹泻]]和[[味觉异常|味觉异常]]。<ref name="gale" />

== 参考资料 ==
{{Reflist}}

== 外部链接（英文） ==
* [http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Mesna.htm 卑诗癌症中心药物信息]
* [http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a695034.html 美国国家卫生研究院药物信息]

{{抗肿瘤治疗的解毒剂}}

[[Category:化疗佐剂|Category:化疗佐剂]]
[[Category:硫醇|Category:硫醇]]
[[Category:有机酸钠盐|Category:有机酸钠盐]]